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Reply
We would like to express our thanks for the valuable comment of
Dandel et al. (1) on our recent article in the Journal (2) regarding
the use of tissue Doppler imaging (TDI) as a new prognosticator
in cardiac diseases. The authors draw attention to the potential role
of TDI in cardiac transplantation. We recognize their unique work
using myocardial systolic and early diastolic velocities, as well as
acceleration for detecting transplant rejection and coronary heart
disease (3). Because our article was a review, we aimed to provide
a useful overview of TDI applications, in particular for common
cardiac diseases. Therefore, we did not include after-cardiac-
transplant patients because they are not commonly encountered in
the clinical practice of most physicians. Furthermore, the article
mainly explored the role of established TDI parameters for
estimating prognosis in terms of major cardiovascular events
and/or mortality. Therefore, it included mostly studies that had at
least medium-term follow-up for the prediction of hard cardiovas-
cular events. Although transplant rejection and development of
coronary heart disease may indicate a worse prognosis, we would
be very interested to see such follow-up data provided by this group
and others.
With respect to the prognostic role of deformation imaging, we
are intrigued by the extensive application of 2-dimensional strain
and strain rate imaging in various patients who received cardiac
surgery or cardiac surgical devices. However, many of these
potential applications still lack major published data to support
their regular clinical usage, not to mention their prognostic role,
which will need additional follow-up assessment. Lastly, although
2-dimensional speckle tracking analysis of strain has been recently
validated (4) as another technique for deformation imaging, more
studies are needed to characterize the clinical application(s) of this
new tool, including its value as a prognosticator.
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Physicians Are Not
Immune to Marketing
We were pleased that your recent editorial “Your Soul for a Pen?”
(1) explored an issue of paramount importance for medicine today.
Aggressive marketing to physicians has created real and perceived
conflicts of interest and casts doubt on the appropriateness of
treatment choices. The editorial observes, and we concur, that
lavish gifts with no educational component must be eliminated and
that gifts of any size erode public trust in the medical community.
The evidence for these points is overwhelming; we, too, are aware
of the research showing that even small gifts can affect prescribing
behavior. We also agree that drug companies would not dispense
token gifts unless they had impact.
We were, therefore, surprised and dismayed that the editorial
went on to maintain that physicians are able to resist the influence
of gifts. Gifts do set off powerful psychosocial dynamics, promot-
ing a felt need, conscious or unconscious, to reciprocate. No less
important, gifts serve as an entrée to physicians’ offices so that drug
reps can promote their products.
For these reasons, The Prescription Project is working to
promote policies that more effectively govern financial ties between
the medical profession and industry. These include a ban on gifts.
Ensuring that physician-industry relationships are free of conflicts
of interest and that physicians base their prescribing decisions on
accurate and unbiased information is essential to sound medical
practice and public confidence in the profession.
*Rob Restuccia
David J. Rothman
Susan Chimonas
Marcia Hams
*Executive Director
The Prescription Project
30 Winter Street
10th Floor
Boston, Massachusetts 02108
E-mail: rrestuccia@communitycatalyst.org
doi:10.1016/j.jacc.2007.05.048
REFERENCE
1. DeMaria A. Your soul for a pen? J Am Coll Cardiol 2007;49:1220–2.
Reply
As is apparent from the letter by Mr. Restuccia and colleagues, we
are in agreement on most, and notably the most important, issues
regarding interaction between physicians and medical industry (1).
Where we seem to disagree is in the matter of degree. I believe
there are gradations in the magnitude of “gifts,” and that gifts of
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